Month: April 2016

Pancreatic cancer is quite possibly the most difficult form of malignancy to treat, largely because it is very hard to diagnose. While the cancer is relatively common, leading to approximately 53,000 new diagnosis every year, the prognosis is rarely favorable. For patients diagnosed with stage II pancreatic cancer, the 5-year survival rate is between 5% …

Pancreatic Cancer: Hard To Diagnose, Hard To Treat Read More »

Immunotherapy is still the new kid on the block, but cancer researchers are already pouring huge amounts of effort into this potential breakthrough methodology, which seeks to harness the body’s own immune system to fight tumors. The government is pouring in money for immunotherapy, too. It’s one of the approaches Vice President Joe Biden says …

Hacking Immunity: How 4 Radical Immunotherapy Techniques Work Read More »

new study published in the Annals of Internal Medicine suggests that while pathologists usually agree in diagnosing cases of invasive breast cancer, they’re more likely to contradict one another when looking at biopsy slides that show precancerous lesions or non-invasive tumors. The study, titled “Variability in Pathologists’ Interpretations of Individual Breast Biopsy Slides: A Population Perspective” was …

Do Pathologists “See” Breast Cancer In Benign Biopsy Samples? Read More »